The 13-valent vaccine for young kids was shown more effective than the 23-valent version for older adults.
A 66-year-old United Arab Emirates (UAE) man who owns camels has the latest confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, the World Health Organization (WHO) announced in a statement today.
Immunization coverage in US adults for diseases other than influenza improved modestly in a few categories in 2012, but coverage in most target groups did not improve, the Centers for Disease Control and Prevention (CDC) reported today.
The largest US outbreak so far of bacteria producing the enzyme NDM (New Delhi metallo-beta-lactamase), which confers resistance to most antibiotics, has been linked to a Chicago area hospital, according to the Chicago Sun-Times and the Centers for Disease Control and Prevention (CDC). The contamination was traced to endoscopic equipment.
Three major infectious-disease societies said this week that healthcare personnel (HCP) should be required to receive all six vaccines that are recommended for them by the federal Advisory Committee on Immunization Practices (ACIP).
Saudi Arabia's health ministry today announced two more Middle East respiratory syndrome coronavirus (MERS-CoV) infections, one of which appears to be in a health worker with an asymptomatic infection who had contact with a confirmed case, according to a machine-translation of a statement posted on the ministry's Web site.
WHO-led malaria vaccine development group announces new goals and a wish list for future vaccines.
An analysis of Dallas County's massive West Nile virus (WNV) outbreak in 2012 found that it was preceded by an unusually mild winter and favored previously known hot spots, researchers reported today in the Journal of the American Medical Association (JAMA).
An Egyptian surveillance study found that while H5N1 avian flu viruses were uncommon on commercial poultry farms, more than 10% of backyard and live-market birds harbored the virus, according to a report in the Journal of Virology.
A working group for a vaccine advisory board recommended against a second dose of Tdap vaccine for teens, citing lack of a booster effect.